NPM1‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions

B Falini - American journal of hematology, 2023 - Wiley Online Library
The nucleophosmin (NPM1) gene encodes for a multifunctional chaperone protein that is
localized in the nucleolus but continuously shuttles between the nucleus and cytoplasm …

[HTML][HTML] NPM 1 Mutations in AML—The Landscape in 2023

N Sharma, JL Liesveld - Cancers, 2023 - mdpi.com
Simple Summary The nucleophosmin 1 (NPM1) gene is mutated in approximately one-third
of newly diagnosed acute myeloid leukemia (AML) cases. NPM1mutated AML (NPM1 mut …

[HTML][HTML] Acute myeloid leukemia

A Vakiti, P Mewawalla - 2018 - europepmc.org
Objectives: Identify the epidemiology of acute myeloid leukemia. Describe the physical exam
of a patient with acute myeloid leukemia, Review the management of acute myeloid …

[HTML][HTML] Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

W Fiskus, CP Mill, C Birdwell, JA Davis, K Das… - Blood cancer …, 2023 - nature.com
Monotherapy with Menin inhibitor (MI), eg, SNDX-5613, induces clinical remissions in
patients with relapsed/refractory AML harboring MLL1-r or mtNPM1, but most patients either …

[HTML][HTML] Biomarkers as targets for CAR-T/NK cell therapy in AML

R Shao, Z Li, H Xin, S Jiang, Y Zhu, J Liu, R Huang… - Biomarker …, 2023 - Springer
The most common kind of acute leukemia in adults is acute myeloid leukemia (AML), which
is often treated with induction chemotherapy regimens followed by consolidation or …

[HTML][HTML] Molecular landscape and validation of new genomic classification in 2668 adult AML patients: real life data from the PETHEMA registry

C Sargas, R Ayala, MJ Larráyoz, MC Chillón… - Cancers, 2023 - mdpi.com
Simple Summary Next–Generation Sequencing (NGS) has provided a deeper genetic
understanding of acute myeloid leukemia (AML) that has been recently incorporated into …

[HTML][HTML] Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation

L Chin, CYG Wong, H Gill - International Journal of Molecular Sciences, 2023 - mdpi.com
Mutations in NPM1, also known as nucleophosmin-1, B23, NO38, or numatrin, are seen in
approximately one-third of patients with acute myeloid leukaemia (AML). A plethora of …

Therapeutic targeting of the menin–KMT2A interaction

PR Freire, JA Cutler… - Annual Review of Cancer …, 2024 - annualreviews.org
The direct targeting of chromatin-associated proteins is increasingly recognized as a
potential therapeutic strategy for the treatment of cancer. In this review, we discuss a …

Targeting the undruggable: menin inhibitors ante portas

WCM Dempke, M Desole, P Chiusolo, S Sica… - Journal of Cancer …, 2023 - Springer
Acute myeloid leukaemias harbouring a rearrangement of the mixed lineage leukaemia
gene (MLL) are aggressive haematopoietic malignancies that relapse early and have a poor …

[HTML][HTML] CAR-NK cells for acute myeloid leukemia immunotherapy: past, present and future

L Zhang, Y Meng, H Yao, R Zhan, S Chen… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a deadly disease and the most common leukemia in adult
with clonal heterogeneity and abnormity in myeloid lineages, which has been recognized …